mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.004 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.005 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.007 |